Raymond James Financial’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
112,745
-51,050
-31% -$623K ﹤0.01% 3846
2026
Q1
$1.99M Sell
163,795
-94,007
-36% -$1.29M ﹤0.01% 3360
2025
Q4
$3.62M Sell
257,802
-18,104
-7% -$257K ﹤0.01% 2771
2025
Q3
$3.93M Buy
275,906
+39,089
+17% +$585K ﹤0.01% 2634
2025
Q2
$3.34M Buy
236,817
+26,532
+13% +$407K ﹤0.01% 2677
2025
Q1
$3.6M Buy
210,285
+15,155
+8% +$282K ﹤0.01% 2551
2024
Q4
$3.75M Buy
+195,130
New +$3.69M ﹤0.01% 2505

Other funds holding CCAP

Raymond James Financial's CCAP Position: Q2 2026 in Review

Raymond James Financial reduced its Crescent Capital BDC (CCAP) stake by 31% in Q2 2026, selling an estimated $623K and leaving 112,745 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3846.

Raymond James Financial first reported a position in CCAP in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.93M in Q3 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.

  • Raymond James Financial held 112,745 shares of Crescent Capital BDC worth $1.23M as of Q2 2026.
  • Raymond James Financial sold 51,050 Crescent Capital BDC shares in Q2 2026, an estimated $623K.
  • Crescent Capital BDC made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3846 holding.
  • Raymond James Financial first reported a position in Crescent Capital BDC in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Crescent Capital BDC position peaked at $3.93M in Q3 2025.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.